Skip to Primary Content
Skip to Footer
home
about
products & pipeline
Clinical Trials
Publications
newsroom
investors
Stock Information
Press Releases
Events & Presentations
SEC Filings
ESG
Financial Information
partners
careers
Afrezza.com
818.661.5000
careers
partners
investors
Stock Information
Press Releases
Events & Presentations
SEC Filings
ESG
Financial Information
newsroom
products & pipeline
Clinical Trials
Publications
about
News & Events
December 13, 2020
Afrezza® (insulin human) Inhalation Powder – INT’L
International Expansion: India (Cipla)
T1 and T2 diabetes mellitus (adults)
previous post
next post
×